Skip to content
The Nexus
DossierENTITY

MDMA-assisted therapy

Coverage of MDMA-assisted therapy in the Nexus archive.

Earliest in view: Apr 30 · 15:00 UTCMost recent: Jun 3 · 13:00 UTC
Co-mentioned in this coverage
U.S. Department of Veterans Affairsorganization2Dave Griffithperson1Missouri Senateorganization1President Trumpperson1psilocybin-assisted therapytopic1ibogaine-assisted therapytopic1methylenedioxymethamphetamine (MDMA)topic1post-traumatic stress disorder (PTSD)topic1severe mental health disorderstopic1alcohol use disordertopic1Department of Defenseorganization1PTSDtopic1active-duty US soldiersperson1war on drugstopic1
Recent coverage
  • HEALTHJun 3 · 13:00 UTCMISSOURI INDEPENDENT
    VA clinical trial on psychedelic-assisted therapy gives Missouri lawmakers hope

    Missouri lawmakers, including Rep. Dave Griffith, advocated for psychedelic-assisted therapy clinical trials to address veterans' PTSD and depression. A VA trial on MDMA-assisted therapy and President Trump's executive order to accelerate psychedelic research influenced their efforts, though legislation stalled in the Missouri Senate.

  • HEALTHMay 27 · 18:01 UTCTHE HILL
    VA studying MDMA as treatment for veterans’ PTSD

    The U.S. Department of Veterans Affairs is launching a trial to study the safety and efficacy of MDMA-assisted therapy for treating post-traumatic stress disorder (PTSD) in veterans. The research will also examine its impact on severe mental health disorders and alcohol use disorder.

  • HEALTHApr 30 · 15:00 UTCTHE GUARDIAN WORLD
    Active-duty US soldiers to receive psychedelic drugs for PTSD next year

    Active-duty US soldiers with PTSD will undergo MDMA-assisted therapy in 2024 as part of Department of Defense-funded studies. The therapy aims to help soldiers process trauma, with 186 participants expected to take part in multiple sessions.